| abstract |
The present invention provides the use of fibroblast growth factor-18 (FGF-18) to improve learning and memory. The invention also relates to measured expression levels of FGF-18 in the central nervous system and methods of using such measurements for diagnostic purposes. The present invention appears to be useful in associative learning, enhanced memory, drug development and analysis, and in the treatment of certain diseases associated with impaired hippocampal function, such as Alzheimer's disease dementia. |